Since no one is posting I'll tell you Sci why I am confident that the professor and his team have nailed it now it is only a gut feel and I could be completely wrong but...
When I look at the situation I find it un feasible that someone with the Professor Frasers pedigree and credentials who has worked for fifteen years to develop this vax and the platform on which its based would put the vaccine up for scrutiny if he wasn't extremely confident of its performance.
I think it unlikely that he would allow millions of dollars to be spent along with the time and effort that the trials require only to say "well that didn't work".
My instincts tell me that behind closed doors he and his team have a far greater understanding of how they expect the hsv2 vaccine to perform but for obvious reasons can not give a running commentary. Time will tell.
- Forums
- ASX - By Stock
- AVR
- hsv2 final results
hsv2 final results, page-6
-
-
- There are more pages in this discussion • 94 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVR (ASX) to my watchlist
(20min delay)
|
|||||
Last
$9.91 |
Change
-0.090(0.90%) |
Mkt cap ! $209.4M |
Open | High | Low | Value | Volume |
$10.00 | $10.00 | $9.65 | $70.76K | 7.202K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 300 | $9.80 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$9.91 | 475 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 300 | 9.800 |
1 | 200 | 9.600 |
1 | 2 | 9.540 |
1 | 330 | 9.510 |
2 | 1185 | 9.500 |
Price($) | Vol. | No. |
---|---|---|
9.910 | 475 | 2 |
9.990 | 99 | 1 |
10.000 | 250 | 1 |
10.500 | 10005 | 2 |
11.000 | 5000 | 1 |
Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online